Waite J, Grundy E, Arie T
Int Clin Psychopharmacol. 1986 Apr;1(2):113-26. doi: 10.1097/00004850-198604000-00003.
A multi-centre controlled trial of amitriptyline, dothiepin and mianserin in the treatment of depressive illness was undertaken in psychiatric inpatients over the age of 65. Despite the co-operation of many of the leading practitioners in this field in Great Britain, it proved impossible to recruit sufficient patients for firm conclusions to be drawn. Forty-five patients were entered into the trial, 13 withdrew because of lack of improvement, 4 because of intercurrent physical illness, 3 because of adverse effects of trial medication and 2 because of lack of compliance. Only 11 of the 23 patients completing had a final score on the Hamilton Depression Rating Scale of 10 or less. No treatment showed a significant superiority over the others, nor was there any difference in tolerance.
针对65岁以上的精神科住院患者开展了一项关于阿米替林、多塞平及米安色林治疗抑郁症的多中心对照试验。尽管英国该领域的许多主要从业者予以了合作,但事实证明无法招募到足够多的患者以得出确凿结论。45名患者参与了该试验,13名因病情无改善而退出,4名因并发躯体疾病退出,3名因试验药物的不良反应退出,2名因未遵守规定退出。在完成试验的23名患者中,只有11名患者在汉密尔顿抑郁评定量表上的最终得分在10分及以下。没有一种治疗方法显示出比其他方法有显著优势,耐受性方面也没有差异。